Applications published 25 March 2009

Vapour dispenser with indicator
Porex 2037734*

Methods for treating cystic kidney diseases
Indiana University Research and Technology 2037736*

Proteins, nucleic acids encoding the same, and associated methods of use
University of Medicine and Dentistry of New Jersey 2037737*

Delivery method
Duke University 2037738*

Benzyl-substituted quinoline M1 receptor positive allosteric modulators
Merck & Co 2037739*

• Compsns and methods to enhance reverse cholesterol transport
Reddy US Therapeutics 2037740*

• Compsns and methods relating to novel compounds and targets thereof
The Regents of the University of Michigan 2037741*

• Prevention of nuclear, solar and other radiation-induced tissue damage
IP-6 Research 2037742*

• Compsns of glycopyrronium salt for inhalation
Novartis; Novartis-Pharma 2037879*

• Compsns and methods for treating conditions of the nail unit
Talima Therapeutics 2037880*

• Steroid-containing sustained release intraocular implants and related methods
Allergan 2037881*

• Combination degradable and non-degradable matrices for active agent delivery
SurModics 2037882*

• Inhalant powder containing phenylalanine
Boehringer Ingelheim Pharma 2037883*

• Sustained release formulations of aromatase inhibitors
Novartis 2037884*

• Low dose sublingual tablets of opioid analgesics and preparation process
Ethypharm 2037885*

• Controlled crystallisation of powders
Boehringer Ingelheim Pharma 2037886*

• Oral controlled release formulations of an interleukin-1 beta converting enzyme inhibitor
Vertex Pharmaceuticals 2037887*

• Active agent formulations, methods of making, and methods of use
Mutual Pharmaceutical 2037888*

• Nanostructured lipid carriers containing riluzole and pharmaceutical formulations containing said particles
Consiglio Nazionale Delle Richerche; Universita" Degli Studi Di Catania; Universita" Degli Studi Di Palermo 2037889*

• Oral pharmaceutical compsn of a poorly water-soluble active substance
Solvay Pharmaceuticals; Panacea Biotec 2037890*

• Tablets comprising candesartan cilexetil
Siegfried Generics International 2037891*

• Modified Factor VIII and Factor IX genes and vectors for gene therapy
Askelpios Biopharmaceutical 2037892*

• Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
Novartis 2037893*

• Compsns with controlled pharmacokinetics
Teva Pharmaceutical Industries 2037894*

• Xylitol troches and methods of use
Orahealth 2037895*

• Effervescent granules or granular material
Virbac 2037896*

• An oral pharmaceutical compsn of an anilinopyrimidine, its preparation and use thereof
Ares Trading 2037897*

• Ibuprofen-containing liquid filled hard capsules
McNeil-PPC 2037898*

• Nanoparticles for nucleic acid delivery
Aarhus Universitet 2037899*

• Treatment of excess sebum production
Summit (Cambridge) 2037890*

• Use of pharmaceutical compsns comprising cannabigerol for the treatment of depression
GW Pharma 2037901*

• Cannabinoids for use in the treatment of neuropathic pain
GW Pharma 2037903*

• Combination methods of treating cancer
Ramot at Tel-Aviv University 2037903*

• Basic acetophenones as inhibitors of NO-synthesis
Christian-Albrechts-Universitaet zu Kiel 2037904*

• Treatment of vasomotor symptoms with selective estrogen receptor modulators
Radius Health; Eisai R&D Management 2037905*

• S1P receptor modulators for treating multiple sclerosis
Novartis 2037906*

• Method for treatment of wound using aganocides
NovaCal Pharmaceuticals 2037908*

• Solid dose formulations of a thrombin receptor antagonist
Schering 2037909*

• Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischaemia
Neurokey 2037910*

• Compsn comprising chrysine and cholic acid for reduction of weight, acceleration of lipolysis and/or restriction of calories
Valora Unternehmensberatung und -beteiligung 2037912*

• Treatment of erectile dysfunction and libido enhancement
CSIR 2037913*

• A suspension comprising benzimidazole carbamate and a polysorbate
Intervet International 2037914*

• Phenol derivatives for the treatment of respiratory diseases
Novartis 2037915*

• Pure isomers of tritoqualine
Nicolau, Mike; Loria, Emile; Terrasse, Gaetan; Trehin, Yves 2037916*

• Pharmaceutical compsn comprising amlodipine and losartan
Hanmi Pharm 2037917*

• Pharmaceutical formulations of pimavanserin
Acadia Pharmaceuticals 2037918*

• Method of using substituted piperidines that increase P53 activity
Schering 2037919*

• Cannabinoid CB1 receptor antagonist for preparation of drugs useful for the prevention and treatment of benign prostatic hypertrophy
Sanofi-Aventis 2037920*

• Sugar-free storage-stable antihistaminic syrups
Schering 2037921*

• Prolyl hydroxylase inhibitors
SmithKline Beecham 2037922*

• Bicyclic heteroaryl inhibitors of PDE4
Govek, Steven; Shiau, Andrew; Noble, Stewart; Thomas, David 2037923*

• Combinations comprising 5HT6 modulators and cholinesterase inhibitors
Epix Delaware 2037925*

• Use of PKC inhibitors in diabetic complications
Novartis 2037926*

• Flibanserin for the treatment of urinary incontinence and related diseases
Boehringer Ingelheim International; Boehringer Ingelheim Pharma 2037927*

• Method for treating atherosclerosis
Amgen 2037928*

• Compsns and methods for ameliorating hyperlipidaemia
San Diego State University Research Foundation 2037929*

• The use of 1,4-diaryl-dihydropyrimidin-2-on derivatives for treating pulmonary arterial hypertension
Bayer HealthCare 2037930*

• Pharmaceutical combinations of PK inhibitors and other active agents
Astex Therapeutics; The Institute of Cancer Research 2037931*